Φορτώνει......
COST-EFFECTIVENESS OF USING HUMAN PAPILLOMAVIRUS 16/18 GENOTYPE TRIAGE IN CERVICAL CANCER SCREENING
OBJECTIVE: Testing for human papillomavirus (HPV) 16 and 18 genotypes, which are known to cause more than 65-70% of invasive cervical cancer cases, may allow clinicians to identify women at highest risk for underlying high-grade dysplasia missed by Pap cytology. Our objective was to determine the co...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Gynecol Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2010
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4568837/ https://ncbi.nlm.nih.gov/pubmed/20713299 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2010.07.004 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|